Cranial nerve injury during transcarotid transcatheter aortic valve replacement.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 Apr 2022
Historique:
received: 02 12 2021
revised: 26 01 2022
accepted: 28 01 2022
pubmed: 4 2 2022
medline: 15 4 2022
entrez: 3 2 2022
Statut: ppublish

Résumé

No data exist about cranial nerve injury (CNI) as a potential complication of transcarotid (TC) transcatheter valve replacement (TAVR). This monocentric study included 318 consecutive patients undergoing TC-TAVR from May 2015 to August 2021. CNI occurred in 7 (2.2%) TAVR-TC patients. Five out of the 7 patients (71.4%) had an injury of the laryngeal branch of the vagus nerve, and 2 patients (28.6%) had an injury of the facial nerve. The majority of patients were male (85.7%), with high body mass index (35.6 (IQR: 30.1-37.3) kg/m2). The induced disabilities were clinically important especially for patients with dysphonia. CNI is a potential complication of TC-TAVR likely avoidable by a meticulous surgical technique. Structural heart teams must be aware of this serious setback.

Sections du résumé

BACKGROUND BACKGROUND
No data exist about cranial nerve injury (CNI) as a potential complication of transcarotid (TC) transcatheter valve replacement (TAVR).
METHODS METHODS
This monocentric study included 318 consecutive patients undergoing TC-TAVR from May 2015 to August 2021.
RESULTS RESULTS
CNI occurred in 7 (2.2%) TAVR-TC patients. Five out of the 7 patients (71.4%) had an injury of the laryngeal branch of the vagus nerve, and 2 patients (28.6%) had an injury of the facial nerve. The majority of patients were male (85.7%), with high body mass index (35.6 (IQR: 30.1-37.3) kg/m2). The induced disabilities were clinically important especially for patients with dysphonia.
CONCLUSIONS CONCLUSIONS
CNI is a potential complication of TC-TAVR likely avoidable by a meticulous surgical technique. Structural heart teams must be aware of this serious setback.

Identifiants

pubmed: 35114203
pii: S0167-5273(22)00187-5
doi: 10.1016/j.ijcard.2022.01.061
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

46-48

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Vassili Panagides (V)

Quebec Heart & Lung Institute, Laval University, Quebec City, QC, Canada.

Dimitri Kalavrouziotis (D)

Quebec Heart & Lung Institute, Laval University, Quebec City, QC, Canada.

Eric Dumont (E)

Quebec Heart & Lung Institute, Laval University, Quebec City, QC, Canada.

Robert Delarochellière (R)

Quebec Heart & Lung Institute, Laval University, Quebec City, QC, Canada.

Jean-Michel Paradis (JM)

Quebec Heart & Lung Institute, Laval University, Quebec City, QC, Canada.

Jules Mesnier (J)

Quebec Heart & Lung Institute, Laval University, Quebec City, QC, Canada.

Siamak Mohammadi (S)

Quebec Heart & Lung Institute, Laval University, Quebec City, QC, Canada.

Josep Rodés-Cabau (J)

Quebec Heart & Lung Institute, Laval University, Quebec City, QC, Canada. Electronic address: josep.rodes@criucpq.ulaval.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH